Skip to main content

Table 4 The status of asthma relief drug usage among children in different age groups, regions and city levels

From: Characteristics of medicine use for children with asthma in China: a nationwide population-based study

 

Age groups

 

Regions

 

City levels

 

Children younger than 3 years old

Preschool children

School-age children

P

East China

Central China

West China

P

1st Tier

2nd Tier

3rd Tier

4th and 5th Tier

P

(N = 439)

(N = 967)

(N = 1062)

(N = 1900)

(N = 223)

(N = 345)

(N = 601)

(N = 1268)

(N = 195)

(N = 314)

SABA

Inhalation

255 (58.09%)

470 (48.60%)

329 (30.98%)

 < .0001

951(50.05%)

59(26.46%)

44(12.75%)

 < .0001

179(29.78%)

702(55.36%)

65(33.33%)

108(34.39%)

 < .0001

Oral

47 (10.71%)

327 (33.82%)

10 (0.94%)

 < .0001

144(7.58%)

58(26.01%)

21(6.09%)

 < .0001

36(59.90%)

83(6.55%)

35(17.95%)

69(21.97%)

 < .0001

OCS

158 (36.00%)

270 (27.92%)

217 (20.43%)

 < .0001

406(21.37%)

130(58.30%)

109(31.59%)

 < .0001

67(11.15%)

291(22.95%)

110(56.41%)

177(56.37%)

 < .0001

SAAC

327 (74.49%)

605 (62.56%)

431 (40.58%)

 < .0001

1228(64.63%)

64(28.70%)

71(20.58%)

 < .0001

361(60.07%)

819(64.59%)

97(49.74%)

86(27.39%)

 < .0001

Theophylline

Oral

9 (2.05%)

27 (2.79%)

31 (2.92%)

0.63

49(2.58%)

10(4.48%)

8(2.32%)

0.281

3(0.50%)

19(1.50%)

22(11.28%)

23(7.32%)

 < .0001

Intravenous

60 (13.67%)

113 (11.69%)

109 (10.26%)

0.166

85(4.47%)

60(26.91%)

137(39.71%)

 < .0001

2(0.33%)

72(5.68%)

49(25.13%)

159(50.64%)

 < .0001